Wednesday, February 01, 2012
Tuesday, August 02, 2011
-
Benchmark Updates 8/2 (ERT, GUID, HHS, MUR, Downgrades, Price Target, Reiteration, Analyst Ratings / Tue, 07:02am)
-
Benchmark Lowers PT on Harte-Hanks To $9 (HHS, Price Target, Analyst Ratings / Tue, 05:49am)
Monday, June 27, 2011
-
Rodman & Renshaw Lower Cleveland BioLabs PT to $8 (Analyst Color, CBLI, HHS, Price Target, Analyst Ratings / Mon, 04:42pm)
Monday, May 02, 2011
-
Benchmark Has Hold Rating On Harte-Hanks (HHS) (Analyst Color, HHS, Price Target, Analyst Ratings / Mon, 08:02am)
Friday, April 29, 2011
-
JP Morgan Lowers PT On Harte-Hanks To $11 (HHS, Price Target, Analyst Ratings / Fri, 08:41am)
Monday, March 28, 2011
-
Novavax Granted HHS Contract for VLP Vaccine (NVAX) (Analyst Color, HHS, NVAX, Analyst Ratings / Mon, 01:37pm)
Tuesday, March 01, 2011
-
Novavax Awarded BARDA Contract, Increasing Target to $4 (Analyst Color, HHS, NVAX, Analyst Ratings / Tue, 08:30am)
Wednesday, February 02, 2011
-
JP Morgan Downs HHS To Neutral (HHS, Downgrades, Analyst Ratings / Wed, 08:25am)
Friday, October 08, 2010
Wednesday, June 16, 2010
Wednesday, February 03, 2010
-
The Benchmark Company Lowers the Harte-Hanks (HHS) Bar (Analyst Color, HHS, Analyst Ratings / Wed, 11:45am)
